Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

Introduction: ADVANCE was a large, multinational clinical study conducted over 5 years in type 2 diabetes mellitus (T2DM). In all, 11,140 patients were randomly assigned to receive gliclazide-based intensive glucose control (IGC) or standard glucose control (SGC). IGC was shown to significantly redu...

Full description

Bibliographic Details
Main Authors: Hai-Yen Nguyen-Thi, Nga TQ. Nguyen, Nguyen Dang Tu Le, Maud Beillat, Olivier Ethgen
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Public Health
Subjects:
gliclazide
intensive glucose control
type 2 diabetes mellitus
hyperglycemia
end-stage renal disease
cost-effectiveness
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2020.562023/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2020.562023/full

Similar Items